April 5, 2011 - New Multi-center Trial Results Demonstrate Ability of Corus CAD to Identify Obstructive Coronary Artery Disease and Add Independent Information to Coronary Calcium Scoring by CT Angiography - Results Presented at American College of Cardiology’s Scientific Sessions – CardioDx, a pioneer in the field of cardiovascular genomic diagnostics, announced that data presented at the American College of Cardiology’s 60th Annual Scientific Sessions demonstrate the ability of Corus™ CAD, a blood-based gene expression test, to identify obstructive coronary stenosis while adding independent information to coronary calcium scoring in patients undergoing CT angiography. In this study, the negative predictive value of Corus CAD for identifying obstructive coronary artery disease as assessed by CT angiography exceeded 95%.“The results of this independent cohort provide new support for the high negative predictive value of the Corus CAD test in the identification of obstructive coronary artery disease in stable patients being noninvasively assessed,” said Szilard Voros, M.D., of The Piedmont Heart Institute Physicians group in Atlanta, the investigator who presented the results. “The ability of gene expression testing to provide independent information to a noninvasive imaging modality like coronary calcium scoring can empower more comprehensive decision-making about patient management.”... CardioDx's Press Release -
